Canadian medical marijuana producer
Aphria Inc. (
TSX: APH,
OTCQB: APHQF,
Forum) reported Thursday that it will be able to process more than 200 tonnes of cannabis annually.
This comes from a new $55 million facility the Company is planning to build to produce concentrated products, such as oils. APH is raising
$225 million to pay for this and other new cannabis facilities, as well as expanding existing operations and potential global expansion and acquisitions.
Aphria entered into an agreement with
Clarus Securities Inc., which has agreed to purchase, on a “bought deal” basis, 18,987,400 common shares of the Company at a price of $11.85.
After announcing the news on Wednesday, APH shares closed up 63 cents to $12.79.